NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

56 hedge funds and large institutions have $1.02M invested in Navidea Biopharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.

Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TSS
1
Two Sigma Securities
New York
$7K
2
CAG
2
Csenge Advisory Group
Florida
$4K
3
SS
3
Simplicity Solutions
Minnesota
$2K
4
Millennium Management
4
Millennium Management
New York
$2K
5
Bank of America
5
Bank of America
North Carolina
$5K

Top Sellers

1
CWM
1
Cornerstone Wealth Management
Missouri
$0
2
HIIFS
2
Harel Insurance Investments & Financial Services
Israel
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$383K
4
SFS
4
Sowell Financial Services
Arkansas
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SFS
51
Sowell Financial Services
Arkansas
– -$55K -12,020 Closed
Goldman Sachs
52
Goldman Sachs
New York
– -$31K -6,701 Closed
BCM
53
Bridgeway Capital Management
Texas
– -$20K -4,275 Closed
CPIG
54
Chicago Partners Investment Group
Illinois
– -$1K -174 Closed
CWM
55
Cornerstone Wealth Management
Missouri
– -$1.13M -25 Closed
1 2
3